Aandeel AEMD AETHLON MEDICAL, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Aethlon Medical, Inc. OTC Bulletin Board

Aandelen

AEMD

US00808Y1091

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
What's Next in Treatments for Cancer Patients with Solid Tumors?
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier Cancer Trial
Top Small-Cap Stocks Leading the Market Surge: ASNS, PRSO, RELI, VTAK, AEMD
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
Aethlon Medical, Inc. Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
Exploring Top NASDAQ Stocks Under $1 Gaining Traction: KITT, AEMD, VTAK, TELL, KWE
The Hunt for Virus Treatments Continues Post Covid-19
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
Top Midday Decliners
Aethlon Medical Announces Pricing of $4.7 Million Public Offering
Aethlon Medical Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma
Aethlon Medical : Corporate Overview – May 2024
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers AEMD
  4. Koers AEMD
  5. Nieuws Aethlon Medical, Inc.
  6. Andere talen